Apteki 36.6 (APTK) Debt/EBITDA MSFO (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 13.5 | 3.90 | 4.04 | 3.16 | 2.57 | 2.70 | |||
| Changes by years, y/y, % | +62% | -71% | +4% | -22% | -19% | -21.0% | |||
Apteki 36.6. Debt/EBITDA
Apteki 36.6. Debt/EBITDA, changes, %
Apteki 36.6 (APTK) Debt/EBITDA MSFO (quarter values) |
||||||||
| 2024Q2 | 2024Q4 | 2025Q2 | 2025Q4 | 2026Q2 | LTM ? | |||
| Debt/EBITDA | 3.38 | 3.16 | 3.66 | 2.57 | 1.79 | 2.70 | ||
| Changes by years, y/y, % | -62% | -22% | +8% | -19% | -51% | |||
| Changes by quarters, q/q, % | -16% | -7% | +16% | -30% | -30% | |||